Claims
- 1. A high calcium chemically defined animal cell culture medium, including:
- (a) SPRD-110 synthetic basal medium;
- (b) retinoid at a concentration of from about 0.01 to bout 1.0 mg/l;
- (c) vitamin D at a concentration of from about 0.01 to about 0.5 mg/l;
- (d) linoleic acid or its ester at a concentration of from about 0.01 mg/l to about 1 mg/l; and
- (e) calcium at a concentration of from about 0.1 mM to about 1.4 mM.
- 2. The culture medium of claim 1, wherein the retinoid is one or more of retinyl acetate, retinol, retinal, retinoic acid, and retinyl palmitate.
- 3. The culture medium of claim 1, wherein the retinoid is retinyl acetate.
- 4. The culture medium of claim 1, wherein the vitamin D is a reduction product of vitamin D.sub.2, dihydrotachysterol.
- 5. The cell culture medium of claim 3, wherein the retinyl acetate is present at a concentration of about 0.115 mg/l.
- 6. The cell culture medium of claim 1, wherein the vitamin D is vitamin D.sub.2, and is present at a concentration of 0.100 mg/l.
- 7. The cell culture medium of claim 1, wherein the linoleic acid is present at a concentration of about 0.100 mg/l.
- 8. The culture medium of claim 1, wherein the calcium is present at a concentration of about 1.2 mM.
- 9. A high calcium chemically defined animal cell culture medium, including:
- (a) a SPRD-110 synthetic basal medium;
- (b) retinyl acetate at a concentration of from about 0.01 to about 1.0 mg/l;
- (c) ergocalciferol at a concentration of from about 0.01 to about 0.5 mg/l;
- (d) linoleic acid at a concentration of from about 0.01 mg to about 1.0 mg/l; and
- (e) calcium at a concentration from about 0.1 mM to about 1.4 mM.
- 10. The culture medium of claim 9, wherein the retinyl acetate is present at a concentration of about 0.115 mg/l.
- 11. The culture medium of claim 9, wherein the ergocalciferol is present at a concentration of about 0.100 mg/l.
- 12. The culture medium of claim 9, wherein the linoleic acid is present at a concentration of about 0.100 mg/l.
- 13. The culture medium of claim 9, wherein the calcium is present at a concentration of about 1.2 mM.
- 14. A method for preparing a tissue culture medium high in calcium and suitable for the primary culture of epidermal cells comprising mixing together the following:
- (a) SPRD-110 synthetic basal medium;
- (b) retinoid at a concentration of from about 0.01 to about 1.0 mg/l;
- (c) vitamin D at a concentration of from about 0.01 to about 0.5 mg/l;
- (d) linoleic acid or its ester at a concentration of from about 0.01 mg/l to about 1 mg/l; and
- (e) calcium at a concentration of from about 0.1 mM to about 1.4 mM.
- 15. The method of claim 14 wherein the retinoid is one or more of retinyl acetate, retinol, retinal, retinoic acid, and retinyl palmitate.
- 16. The method of claim 14 wherein the retinoid is retinyl acetate.
- 17. The method of claim 14 wherein the vitamin D is a reduction product of vitamin D.sub.2, dihydrotachysterol.
- 18. The method of claim 16 wherein the retinyl acetate is present at a concentration of about 0.115 mg/l.
- 19. The method of claim 14 wherein the vitamin D is vitamin D.sub.2,and is present at a concentration of 0.100 mg/l.
- 20. The method of claim 14 wherein the linoleic acid present at a concentration of about 0.100 mg/l.
- 21. The method of claim 14 wherein the calcium is present at a concentration of about 1.2 mM.
- 22. A method for preparing a tissue culture medium high in calcium and suitable for the primary culture of epidermal cells comprising mixing together the following:
- (a) SPRD-110 synthetic basal medium;
- (b) retinyl acetate at a concentration of from about 0.01 to about 1.0 mg/l;
- (c) ergocalciferol at a concentration of from about 0.01 to about 0.4 mg/l;
- (d) linoleic acid at a concentration of from 0.01 mg to about 1.0 mg/l; and
- (e) calcium at a concentration of from about 0.1 mM to about 1.4 mM.
- 23. The method of claim 22 wherein the retinyl acetate is present at a concentration of about 0.115 mg/l.
- 24. The method of claim 22 wherein the ergocalciferol is present at a concentration of about 0.100 mg/l.
- 25. The method of claim 22 wherein the linoleic acid is present at a concentration of about 0.100 mg/l.
- 26. The method of claim 22 wherein the calcium is present at a concentration of about 1.2 mM.
Parent Case Info
This is a divisional of copending application Ser. No. 337,143, filed Apr. 12, 1989 now U.S. Pat. No. 5,126,261, issued Jun. 30, 1992.
Government Interests
The United States government may have rights in this patent because of relevant developmental work supported by Research Grant No. CA43278 from National Institutes of Health.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5126261 |
Morris et al. |
Jun 1992 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
337143 |
Apr 1989 |
|